SHAREHOLDERS' EQUITY (Tables)

12 Months Ended

Dec. 31, 2024

SHAREHOLDERS' EQUITY

Summary of information about stock options under the Plan

				Weighted
		Weighted		Average
		Average		Remaining
	Number of	Exercise		Contractual	Intrinsic
	Shares	Price		Life (Years)	Value
	(in thousands, except per share and year data)
Balance at December 31, 2021	617	$	13.43	4.2	$	53
Forfeited	(159)		12.27	—		2
Expired	(10)		28.70	—		—
Balance at December 31, 2022	448	$	13.43	2.6	$	—
Granted	630		7.22	—		—
Forfeited	(67)		11.45	—		3
Balance at December 31, 2023	1,011	$	9.69	3.0	$	61
Exercised	(8)		7.10	—		6
Forfeited	(75)		10.56	—		49
Expired	(95)		16.70	—		—
Balance at December 31, 2024	833	$	8.84	2.7	$	352
Exercisable at December 31, 2024	448	$	10.23	2.0	$	115

Schedule of weighted-average assumptions used for estimation of the fair value of the options granted under the Plan at the date of grant, using the Black-Scholes Option Valuation Model

	2024		2023	2022
Risk-free interest rate	—		4.44%	—
Dividend yield	—		0.00%	—
Volatility factor of the expected market price of common stock	—		67%	—
Weighted-average expected life of option	—		3 years	—
Weighted-average grant date fair value	—	$	3.36	—

Summary of status and activity of non-vested stock options

		Weighted Average
		Grant Date
	Number of	Fair Value
	Shares	Per Share
	(in thousands, except per share amounts)
Non-vested balance at December 31, 2023	623	$	3.39
Forfeited	(27)	$	3.36
Vested	(211)	$	3.43
Non-vested balance at December 31, 2024	385	$	3.37

Schedule of Restricted Stock Units

	Number of Shares
	(in thousands)
Balance at December 31, 2021	—
Granted	—
Vested and issued	—
Balance at December 31, 2022	—
Granted	109
Vested and issued	(80)
Balance at December 31, 2023	29
Granted	258
Vested and issued	(273)
Balance at December 31, 2024	14